MYDECINE
Creating a healthier world through adaptive pathway medicines, natural health products and digital health solutions
Revolutionizing Natures Medicine for Mental Health & Vitality
Revolutionizing Nature's Medicine
for Mental Health & Vitality

Our Mission

Our mission is to create a healthier world through advanced technologies, natural products, and psychedelic derived medicines. We were founded on the belief that innovation is needed to improve on existing products and mental health services. Our goal is to change the way you think about holistic health by delivering premium quality products and services that enhance your life.

Our Story

We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.
---VIDEO---

About Us


Mydecine Innovations Group™️ is a publicly traded life sciences parent company dedicated to the development and production of adaptive pathway medicine, natural health products and digital health solutions.

Mydecine’s experienced cross functional teams have the dynamic capabilities to oversee all areas of medicine development including synthesis, genetic research, import/export, delivery system development, clinical trial execution,through to product commercialization and distribution. By leveraging strategic partnerships with scientific, medical, military, and clinical organizations, Mydecine™️ is positioned at the forefront of psychedelic medicine naturally derived from fungi, therapeutic solutions, and fungtional™️ mushroom vitality products.

Our portfolio of unified companies, including Mydecine Health Sciences™️, Mindleap Health™️, and NeuroPharm™️ focus on providing innovative and effective options that can provide millions of people with a healthier quality of life.
Mydecine Health Sciences Logo
NeuroPharm Inc.™️ (NPI) is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations.
Learn MoreLearn More
Mindleap Health™️ is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind.
Mydecine’s spore-to-sale™️ operational extension of the Company, Mydecine Health Sciences™️ (“MHS”), is taking a two-pronged approach and focusing on both psychedelic (clinical) and fungtional™️ (consumer) avenues of commercializing fungi.
Learn More

Our Portfolio

Natural Health Products
Learn More→
We are discovering, extracting, and combining powerful fungtional© and psychedelic ingredients in mushrooms to enhance and balance the brain.
Research & Development
We are charting new paths with Neurological Disorder Medicines based on the novel compounds found in psychedelic medicines.
Learn More→
Learn More→Digital Health Solutions
We are developing breakthrough digital technologies to augment mental healthcare with data, digital therapeutics, and global connectivity.

Our Portfolio

Natural Health Products
Learn More→
We are discovering, extracting, and combining powerful fungtional© and psychedelic ingredients in mushrooms to balance and enhance the brain.
Research & Development
We are charting new paths with Neurological Disorder Medicines based on the novel compounds found in psychedelic medicines.
Learn More→
Learn More→Digital Health Solutions
We are developing breakthrough digital technologies to augment mental healthcare with data, digital therapeutics, and global connectivity.

Our Story

We started Mydecine Innovations Group with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.

We are inspired by the future, the innovators, the dreamers; and our products embody this  spirit. They are built for those that aspire to be healthy physically and spiritually while living life to the fullest and daring to disrupt the norm.

Our passion sent us on a mission to develop high quality products and disruptive new technologies so we can contribute to making the world a better place.

Our Brands

Mydecine is our core brand. We started Mydecine Innovation with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Kured was started with the goal of revolutionizing the way people live and experience life by offering cutting edge natural products and technologies. Our international team has been described as a collection of passionate business leaders, scientists, mental health professionals and technology visionaries.
Fresh CBD Water is infused with CBD, a naturally occurring cannabinoid in hemp, that has shown to have effects that include analgesic, anti-inflammatory, anti-oxidant, anti-emetic, anti-anxiety, anti-psyc
Mindleap Health was founded by purpose-driven leaders on a mission to enhance the wellbeing of millions of people that struggle with mental health problems. By combining traditional telemedicine, psychedelic medicine and advanced mood and behavior tracking and analytics, the Mindleap platform offers a powerful set of tools for managing mental healthcare.

For Investors

Ticker Symbols
CSX: MYCO
OTC: MYCOF
FSE: 0NFA
SEDAR ProfileInvestor Presentation
1d
5d
1m
6m
ytd
1y
5y
See All News →

Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD

August 13, 2020
NeuroPharm Inc. was recently covered in Forbes for its ground-breaking psilocybin clinical trials for treatment of posttraumatic stress disorder (PTSD)
Read More →

First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans

August 12, 2020
Psychedelics-based treatments developer NeuroPharm Inc. recently announced it would be collaborating on clinical trials for the treatment of posttraumatic stress disorder (PTSD)
Read More →

Mydecine Innovations Group Provides Inaugural Corporate Update in the Expanding Psychedelic Medicines Sector

August 12, 2020
Mydecine Innovations Group Inc. is pleased to provide a corporate update regarding recent advancements and achievements that continues to add shareholder value
Read More →
News & Media